![Massimo Muzzi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Massimo Muzzi
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
CMR Surgical Ltd.
![]() CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom.
3
| Holding Company | Medical Specialties | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Massimo Muzzi
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Capital Group Private Markets, Inc UK Branch | Investment Managers | Private Equity Investor | |
University of Cambridge | College/University | Graduate Degree | |
PetMedix Ltd.
![]() PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Microbiotica Ltd.
![]() Microbiotica Ltd. BiotechnologyHealth Technology Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Exvastat Ltd.
![]() Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Congenica Ltd.
![]() Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Biotechnology | Director/Board Member | |
Morphogen-IX Ltd.
![]() Morphogen-IX Ltd. Miscellaneous Commercial ServicesCommercial Services Morphogen-IX Ltd. operates as a biotechnology company. It develops bone morphogenetic proteins as a novel therapy for the treatment of Pulmonary Arterial Hypertension. The company was founded in 2015 and is headquartered in Babraham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Inivata Ltd.
![]() Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Packaged Software | Director/Board Member | |
Royal College of Obstetricians & Gynaecologists | College/University | Corporate Officer/Principal | |
Abcodia Ltd.
![]() Abcodia Ltd. BiotechnologyHealth Technology Abcodia Ltd. engages in the validation and discovery of molecular biomarkers. The firm works alongside University College London and in partnership with diagnostic, pharmaceutical and technology companies to exploit a prospective serum bank for the purpose of ethical biomarker validation and discovery. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Cambridge Innovation Capital Ltd
![]() Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Private Equity Investor | |
Avilex Pharma ApS
![]() Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
Sosei R&D Ltd.
![]() Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Amoun Pharmaceutical Co. SAE
![]() Amoun Pharmaceutical Co. SAE Pharmaceuticals: MajorHealth Technology Amoun Pharmaceutical Co. SAE manufactures and distributes human and veterinary pharmaceutical products and food supplements. The firm’s products include analgesics, anti-infectives, cardiovascular and gastrointestinal drugs and drugs for anesthesia, genito-urinary disorders, and respiratory systems. The company was founded by Sarwat Bassily in 1976 and is headquartered in Cairo, Egypt. | Pharmaceuticals: Major | Director/Board Member | |
KalVista Pharmaceuticals Ltd.
![]() KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University College London | College/University | Undergraduate Degree | |
London Business School | College/University | Masters Business Admin | |
Vantia Ltd.
![]() Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
CCMP Capital Advisors (UK) LLP | Investment Managers | Private Equity Investor | |
LGT Impact Ventures (UK)
![]() LGT Impact Ventures (UK) Investment ManagersFinance LGT Impact Ventures (UK) (LGT Impact Ventures) is a private equity subsidiary of LGT Group Foundation founded in 2014. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
KALERA PUBLIC LIMITED COMPANY | Agricultural Commodities/Milling | Director/Board Member | |
Satispay SpA
![]() Satispay SpA Packaged SoftwareTechnology Services Satispay SpA operates a mobile payment application. It allows users to send money and pay in stores and online. The company was founded by Alberto Dalmasso, Dario Brignone, and Smauele Pinta in 2013 and is headquartered in Milan Italy. | Packaged Software | Director/Board Member | |
Macalester College | College/University | Undergraduate Degree | |
Pretzel Therapeutics, Inc.
![]() Pretzel Therapeutics, Inc. BiotechnologyHealth Technology Pretzel Therapeutics, Inc. is an American biotechnology company that develops therapies by utilizing mitochondrial biology. Pretzel Therapeutics is based in an undisclosed location and has research facilities in another undisclosed location. The company aims to develop treatments that address the genetic causes of mitochondrial dysfunction. The company was founded by academic experts in mitochondrial biology and is supported by a world-class investor syndicate. Jay Parrish has been the CEO of the company since 2021. | Biotechnology | Director/Board Member |
Statistik
International
Vereinigtes Königreich | 19 |
Vereinigte Staaten | 4 |
Dänemark | 2 |
Ägypten | 2 |
Italien | 2 |
Sektoral
Health Technology | 11 |
Consumer Services | 6 |
Finance | 5 |
Commercial Services | 3 |
Technology Services | 3 |
Operativ
Director/Board Member | 14 |
Private Equity Investor | 4 |
Undergraduate Degree | 2 |
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Robert Tansley | 18 |
Sakip-Umur Hürsever | 9 |
Egor Kulkov | 1 |
- Börse
- Insiders
- Massimo Muzzi
- Unternehmensverbindungen